Zhengkang Luo

Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes

Luo, Zhengkang; Mejia Cordova, Mariela; Hamze, Nour; Berggren, Elin et al.

Part of Endocrine, p. 626-637, 2024

• DOI for Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
• Download full text (pdf) of Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes

Diabetic complications and prospective immunotherapy

Reynolds, Lewis; Luo, Zhengkang; Singh, Kailash

Part of Frontiers in Immunology, 2023

• DOI for Diabetic complications and prospective immunotherapy
• Download full text (pdf) of Diabetic complications and prospective immunotherapy

Immunological strategies for counteracting type 1 diabetes focusing on IL-35 producing regulatory immune cells

Luo, Zhengkang

2023

• Download full text (pdf) of Immunological strategies for counteracting type 1 diabetes focusing on IL-35 producing regulatory immune cells

Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes

Luo, Zhengkang; Soläng, Charlotte; Larsson, Rasmus; Singh, Kailash

Part of International Journal of Molecular Sciences, 2022

• DOI for Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes
• Download full text (pdf) of Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes

Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development

Singh, Kailash; Bricard, Orian; Haughton, Jeason; Björkqvist, Mikaela et al.

Part of Biomolecules, 2022

• DOI for Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development
• Download full text (pdf) of Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development

Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes

Luo, Zhengkang; Mejia Cordova, Mariela; Hamze, Nour; Berggren, Elin et al.

Part of Endocrine, p. 626-637, 2024

• DOI for Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes
• Download full text (pdf) of Assessing the Effectiveness of Interleukin-2 Therapy in Experimental Type 1 Diabetes

Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes

Luo, Zhengkang; Soläng, Charlotte; Larsson, Rasmus; Singh, Kailash

Part of International Journal of Molecular Sciences, 2022

• DOI for Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes
• Download full text (pdf) of Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes

Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development

Singh, Kailash; Bricard, Orian; Haughton, Jeason; Björkqvist, Mikaela et al.

Part of Biomolecules, 2022

• DOI for Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development
• Download full text (pdf) of Gene Delivery of Manf to Beta-Cells of the Pancreatic Islets Protects NOD Mice from Type 1 Diabetes Development

Aspects of univalence in holographic axion models

Baggioli, Matteo; Grieninger, Sebastian; Grozdanov, Saso; Luo, Zhengkang

Part of Journal of High Energy Physics (JHEP), 2022

• DOI for Aspects of univalence in holographic axion models
• Download full text (pdf) of Aspects of univalence in holographic axion models

Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells

Luo, Zhengkang; Lundin, Sara; Mejia Cordova, Mariela; Hassani, Imane et al.

Part of International Journal of Molecular Sciences, 2021

• DOI for Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells
• Download full text (pdf) of Interleukin-35 Prevents Development of Autoimmune Diabetes Possibly by Maintaining the Phenotype of Regulatory B Cells

Significance of host heparanase in promoting tumor growth and metastasis

Zhang, Gan-Lin; Gutter-Kapon, Lilach; Ilan, Neta; Batool, Tahira et al.

Part of Matrix Biology, p. 25-42, 2020

• DOI for Significance of host heparanase in promoting tumor growth and metastasis

Determination of Regulatory T Cell Subsets in Murine Thymus, Pancreatic Draining Lymph Node and Spleen Using Flow Cytometry

Luo, Zhengkang; Thorvaldson, Lina; Blixt, Martin; Singh, Kailash

Part of Journal of Visualized Experiments, 2019

• DOI for Determination of Regulatory T Cell Subsets in Murine Thymus, Pancreatic Draining Lymph Node and Spleen Using Flow Cytometry

The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors

He, Qi; Li, Xiujuan; Singh, Kailash; Luo, Zhengkang et al.

Part of Scientific Reports, 2019

• DOI for The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
• Download full text 1 (pdf) of The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors
• Download full text 2 (pdf) of The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors

Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes

Luo, Zhengkang; Soläng, Charlotte; Mejia Cordova, Mariela; Thorvaldson, Lina et al.

Part of FASEB BioAdvances, p. 538-549, 2019

• DOI for Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes
• Download full text (pdf) of Kinetics of immune cell responses in the multiple low dose streptozotocin mouse model of type 1 diabetes

Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes

Singh, Kailash; Martinell, Mats; Luo, Zhengkang; Espes, Daniel et al.

Part of Clinical and Experimental Immunology, p. 64-73, 2019

• DOI for Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes
• Download full text (pdf) of Cellular immunological changes in patients with LADA are a mixture of those seen in patients with type 1 and type 2 diabetes

Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas

Li, Xiujuan; Singh, Kailash; Luo, Zhengkang; Mejia Cordova, Mariela et al.

Part of Oncotarget, p. 18720-18733, 2018

• DOI for Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas
• Download full text (pdf) of Pro-tumoral immune cell alterations in wild type and Shb-deficient mice in response to 4T1 breast carcinomas

Kinetics of innate immune and regulatory T cells responses in experimental diabetic nephropathy

Luo, Zhengkang; Varli, Sonya; Enström, Emma; Thorvaldson, Lina et al.

Part of Scandinavian Journal of Immunology, p. 304-304, 2017

Kinetics of the innate immune cell responses in experimental Type 1 Diabetes

Mejia Cordova, Mariela; Soläng, Charlotte; Luo, Zhengkang; Blixt, Martin et al.

Part of Scandinavian Journal of Immunology, p. 303-304, 2017

Diabetic complications and prospective immunotherapy

Reynolds, Lewis; Luo, Zhengkang; Singh, Kailash

Part of Frontiers in Immunology, 2023

• DOI for Diabetic complications and prospective immunotherapy
• Download full text (pdf) of Diabetic complications and prospective immunotherapy

Immunological strategies for counteracting type 1 diabetes focusing on IL-35 producing regulatory immune cells

Luo, Zhengkang

2023

• Download full text (pdf) of Immunological strategies for counteracting type 1 diabetes focusing on IL-35 producing regulatory immune cells